New-onset Uveitis During CTLA-4 Blockade Therapy With Ipilimumab in Metastatic Melanoma Patient

Can J Ophthalmol. 2015 Feb;50(1):e2-4. doi: 10.1016/j.jcjo.2014.10.010.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • CTLA-4 Antigen / antagonists & inhibitors*
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Ipilimumab
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / secondary
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Mydriatics / therapeutic use
  • Prednisolone / analogs & derivatives
  • Prednisolone / therapeutic use
  • Tropicamide / therapeutic use
  • Uveal Neoplasms / drug therapy*
  • Uveal Neoplasms / pathology
  • Uveitis, Anterior / chemically induced*
  • Uveitis, Anterior / drug therapy
  • Vision Disorders / chemically induced
  • Vision Disorders / drug therapy
  • Visual Acuity

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Glucocorticoids
  • Ipilimumab
  • Mydriatics
  • prednisolone acetate
  • Prednisolone
  • Tropicamide